International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2018 - Volume 22, Number 6
View All Articles in Issue

Page(s): 494

Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, enalapril maleate, antihypertensive agent, hypertenion, high blood pressure, angiotensin-converting enzyme inhibitor, ACE inhibitor, oral liquid preparations

Related Categories: EXCIPIENTS, FORMULATIONS, CARDIOLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Enalapril Maleate 1-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 221
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Lisinopril 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 318
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 386
Stability of Captopril in SyrSPend SF Geiger Christine M, Sorenson Bridget, Whaley Paul A	Jul/Aug 2013 Pg. 336-338
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Lisinopril 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 302
Quinapril 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2006 Pg. 227
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Benazepril 2-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 242
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip	Jul/Aug 2023 Pg. 340-346
Brompheniramine Maleate 2-mg/5-mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2003 Pg. 295
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 492
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
Return to Top